शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
JENBURPHBSEJENBURKT PHARMACEUTICAL L· Pharmaceuticals & BiotechnologyHighNeutral
Announced Fri, 4 Sept, 2026 · 21:34 IST

Dilip H. Bhuta reappointed as Whole Time Director and CFO for 5 years

JENBURPH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.1%Reaction day
₹1040.60
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-0.3% vs market
Pharmaceuticals peers, median of 174sector+0.2%-0.1% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.1+0.4-0.3+0.2-0.1
Next day
-0.1+0.9-1.0+0.5-0.6
2d
-1.7+0.8-2.5+0.2-1.9
3d
-0.3+0.6-0.9+0.4-0.6
4d
-2.9+0.7-3.6-0.4-2.6
5d
-6.4-2.6-3.8-1.8-4.5
1w
-5.0-1.9-3.1-1.0-3.9
15d
-10.6-0.6-10.1+0.3-10.9
1m
-14.0-1.0-13.0-0.7-13.3
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 174Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Shareholders at the 41st AGM approved the re-appointment of Shri Dilip H. Bhuta (74 years, DIN 03157252) as Whole Time Director and CFO for 5 years, from April 1, 2027 to March 31, 2032. Remuneration fixed for 3 years till March 31, 2030. He has been on the board since July 2013.

Likely market impact

Continuity at the top. Existing CFO gets a fresh 5-year term, signaling stability in finance and operations leadership.